CompletedPhase 4NCT03996434

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: ClinAmygate
Principal Investigator: Eman Elgendy, MD
International Islamic Centre for Population Studies and Research
Intervention: Gonadotropin(drug)
Enrollment: 300 target
Eligibility: 20-40 years · FEMALE
Timeline: 2019 – 2019

Study locations (2)

Alazahr University, Cairo, Egypt
Assisted Reproduction Unit International Islamic Centre for Population Studies and Research, Al-Azhar University, Cairo, Egypt

Collaborators

Cairo University · Al-Azhar University · Beni-Suef University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03996434 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials